TARA
Protara Therapeutics Inc
3.50$
-1.1%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.8% | 98.6% | 98.2% | 98.9% | 98.8% | 100.0% | 83.4% | 53.9% | 76.0% | 87.0% | 94.9% | 76.1% | |
| 81.2% | 59.3% | 83.6% | 48.1% | 82.4% | 88.6% | 83.0% | 20.7% | 21.3% | 50.1% | 89.7% | 23.7% | |
| 98.6% | 96.6% | 94.9% | 95.8% | 93.0% | 88.6% | 83.0% | 52.9% | 74.5% | 83.1% | 93.8% | 74.3% | |
| – | 1.0% | – | – | – | – | – | 0.4% | 0.4% | 0.3% | – | 0.6% | |
| – | – | – | – | – | – | – | 0.7% | 1.0% | – | – | – | |
| 0.1% | 0.3% | 0.9% | 0.6% | 1.1% | 6.6% | 0.6% | 5.2% | 6.9% | – | – | – | |
| – | – | – | – | – | – | 14.5% | 17.1% | 0.0% | – | – | – | |
| – | – | – | – | – | – | 14.5% | 17.1% | 0.1% | 3.4% | 1.8% | 1.4% | |
| 2.8% | 6.1% | 11.7% | 21.0% | 13.1% | 8.4% | 1.9% | 6.2% | 9.9% | 13.5% | 7.9% | 6.2% | |
| 2.8% | 6.1% | 11.7% | 21.0% | 13.1% | 8.4% | 1.4% | 2.5% | 5.1% | 7.8% | 6.0% | 5.2% | |
| – | – | – | 0.0% | – | – | 0.0% | 0.5% | 0.8% | 1.2% | 0.6% | 0.6% | |
| 1.1% | 1.5% | 1.3% | 0.0% | 1.9% | 10.3% | 0.4% | 0.6% | 1.4% | 3.1% | 2.4% | 1.7% | |
| 97.2% | 93.9% | 88.3% | 79.0% | 86.9% | 91.6% | 98.1% | 93.8% | 90.1% | 86.5% | 92.1% | 93.8% | |
| -129.6% | -194.3% | -367.1% | -431.4% | -894.8% | -3,232.4% | -23.0% | -54.5% | -141.2% | -253.8% | -135.0% | -144.4% | |
| 0.4% | 0.6% | 1.0% | 1.0% | 10.9% | 58.2% | 3.6% | 6.5% | 9.9% | 14.4% | 11.3% | 20.4% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.